Questions? Feedback? powered by Olark live chat software
All Site

Upcoming Webinars

terumo webinar

COVID-19 experts discuss exosomes and mesenchymal stem cells as experimental treatment for ARDs in COVID-19

terumo logo


Friday, June 5, 2020
1:00 A.M. Australian Eastern Standard Time
3:00 A.M. New Zealand   

Also available on Demand                                     

Join us for this timely panel discussion that will cover ongoing research and clinical trials to manage acute respiratory distress syndrome (ARDS) in COVID-19 patients. Two experts will share their extensive experience with therapies using mesenchymal stem cells (MSCs) and the small extracellular vesicles (sEVs) that MSCs produce as potential treatments for COVID-19 patients with ARDS. Jim Beltzer, PhD, from Terumo BCT will facilitate the discussion.11:00 a.m. Eastern Time, USA                                   

In this webinar, we will:

Explore how small extracellular vesicles can recapitulate the therapeutic effect of MSCs
Discuss clinical trial design with critically ill patients (such as those with COVID-19), including strategies for optimizing sample size, managing patient and disease heterogeneity, and maximizing the use of trial data
Learn how the lung inflammatory environment may alter mesenchymal stem cell behaviour

Presented By:

Ben Buller, PhD, Associate Scientist, Henry Ford Health System

Michael Matthay, MD, Professor of Medicine, University of California San Francisco

Jim Beltzer, PhD, Senior Manager, Terumo BCT



Past Webinars

support banner smaller

ACD Biotechne CMYK

RNAscope™ Technology Introduction: How to get started as a new user

Thursday, April 30, 2020
11:00 A.M. Australian Eastern Standard Time
1:00 P.M. New Zealand

The RNAscope® Technology is a novel in situ hybridization (ISH) assay for detection of target RNA within intact cells. The assay represents a major advance in RNA ISH approaches with its proprietary probe design to amplify target-specific signals but not background noise from non-specific hybridization. The RNAscope® Assay is an ideal tool to complement technologies like IHC, qPCR or NGS. In this webinar we will discuss the benefits of RNAscope® assay and share tips and tricks on how to perform these assays successfully to obtain publication-quality RNA in situ results. Please bring your RNAscope® technology questions to the webinar and our team will answer them live during the webinar.
Who should attend:

This webinar will benefit both new and experienced RNAscope® technology users.

Learning Objectives:
  • How RNAscope® assays work
  • What you need to get started
  • Tips and tricks for successful sample preparation
  • Examples of staining results & research application specific data
  • FAQs & Troubleshooting tips

Presented By:
Amrita Roy, PhD
Field Application Scientist
Advanced Cell Diagnostics, Bio-Techne





ATCC logo website

Amplify Your Viral Vaccine Production with CRISPR/Cas9-Engineered Host Cells

Thursday, April 23, 2020
11:00 A.M. Australian Eastern Standard Time
1:00 P.M. New Zealand

Vaccines against viral infections like polio, chickenpox, measles, and viral hepatitis are manufactured by producing large quantities of viral particles in a scaled-up tissue culture system. A handful of historical cell lines like Vero (green monkey kidney) and MDCK (canine kidney) are approved by the FDA for viral vaccine production. However, other than clone selection and substrate adaption, relatively little has been done to improve the inherent viral production capacity of the cell lines. ATCC used CRISPR/Cas9 gene editing to create improved versions of cell lines commonly used for viral vaccine manufacturing. These cells produce model
clinical viruses at titers 10-fold higher than the corresponding parental cell line, which has the potential to significantly reduce costs associated with virus and viral vaccine production.

In this webinar, ATCC Scientist Dr. Liz Gillies will cover these key takeaways:

  • Most viral vaccines are manufactured in large-scale tissue culture systems using historical cell lines that are approved for vaccine manufacturing.
  • ATCC used CRISPR/Cas9 gene-editing techniques to increase the viral production efficiency of some of these historical cell lines.
  • These enhanced virus-producing cell lines have the potential to significantly reduce the costs associated with generating viral vaccines and high-titer viral stocks.

Presented by:
Liz Gillies, Ph.D., Scientist, ATCC


/brands/agilent-technologies-seahorse-bioscience/Combining Seahorse XF Analysis with stable isotope tracing to reveal novel metabolic drug targets

In this webinar, Dr. David Ferrick discusses how advances in our understanding of T cell co-receptors have led to new strategies for keeping immune cells turned on in the suppressive, hostile tumor microenvironment. Much has been learned in the last decade about metabolic reprogramming in cancer, focused initially on tumor metabolism. However, by applying this knowledge to infiltrating immune cells we are now beginning to appreciate the metabolic drivers of immune cell fitness, specifically stable mitochondrial function that can perhaps reverse exhaustion phenotypes by enhancing survival and function in hypoxic and nutritionally depleted tumor microenvironments.

Presented by:
David Ferrick, Ph.D, 
Senior Strategy Director 
Cell Analysis, Agilent




 Join us for our eSeminar presented by Dr. Ping-Chih Ho to learn about Agilent Cell Analysis applications in cancer immunotherapy research. 

The aberrant accumulation of regulatory T cells (Tregs) in tumors promotes immunosuppressive features of the tumor microenvironment (TME). Although depleting Tregs unleashes antitumor immunity and reprograms the immune status of the TME, the therapeutic potential of Treg-targeting is largely compromised due to autoimmunity induced by systemic loss of Tregs. Given that Tregs reside in different locations where they contain distinct nutrient composition, metabolic adaptation should be engaged by Tregs to support their tissue retention and tissue-dependent behavior. This talk discusses how we can selectively demolish intramural Tregs by targeting unique metabolic preference of intratumoral Tregs and how this approach can be utilized for cancer research.

Presented by:
Ping-Chih Ho, Ph.D,
Assistant Professor,
Department of Fundamental Oncology,
University of Lausanne Ludwig Center for Cancer Research.



cell analysis seahorse webinar

Rapid adoption of live cell kinetics and real time biology in the design and validation of adoptive T cell strategies

Adoptive cell therapies have come of age, establishing living cells as a powerful therapeutic modality in terms of specificity, durability and adaptability. Agilent Seahorse technology is enabling the shift to real-time quantification of immune cell function, opening a new window on controlling immune cell fate and outcomes. Several translational research studies have demonstrated that altering metabolic behavior can direct immune responses and outcomes. Move beyond analyzing what your cells are, and reveal a clearer picture of what they do in order to harness their therapeutic potential.

David Ferrick, Ph.D
Senior Director
Cell Analysis Division - Agilent Technologies


ATCC logo websiteSTR Profiling for Human Cell Line Authentication

Over the past few decades, much has been written about misidentification of cell lines, primarily human cell lines. It is not unusual that studies of the ‘same’ cell lines performed by different laboratories often show different results using the same methodology. Hear Dr. Shapiro discuss the implementation of best tissue culture practices to include routine authentication of human cell lines by short tandem repeat (STR) profiling.

Presented by:
Brian Shapiro, Ph.D. Technical Writer, ATCC


ATCC logo websiteThe Art and Science of Growing Animal Viruses in the Laboratory: Best Practices in Virus Culture

Employing good aseptic technique and understanding the specific culture requirements of a strain are essential for optimal viral growth. In this webinar, we will discuss the basic principles for propagating animal viruses in the laboratory. Here, we will highlight best practices for making good virus stocks with an emphasis on the art and science of virus culture that should be followed to help avoid contamination and cross-contamination. Further, we will provide an in-depth look at viral culturing practices in both cell culture and embryonated chicken eggs using Influenza virus as an example.


AgilentQuantifying macrophage activation using Agilent Seahorse XF technology
Metabolism is critical for normal macrophage function - upon activation there is a dramatic metabolic switch towards glycolysis.  In this webinar we will discuss new approaches for quantifying macrophage activation in real time using an Agilent XF analyzer. 

Presented by:
Brian Dranka, Ph.D.
Biology Manager, Seahorse XF Products, Agilent Technologies, Inc.


ATCC logo websiteNew isogenic cell models created by CRISPR genome editing for drug discovery
The recent development of the CRISPR/Cas9 system provides a revolutionary gene-editing technology. It is not only an advanced tool for basic research in biology but also a breakthrough technique for the development of targeted cancer therapies.

Presented by:
Fang Tian,
Ph.D., Lead Scientist, ATCC Cell Systems
Lysa-Anne Volpe, M.S., Senior Biologist, ATCC Cell Systems




Agilent Metabolic reprogramming in macrophages during inflammation
Macrophages undergo profound metabolic changes when they are being activated. A major event is a switch to glycolysis which occurs in response to the bacterial product LPS. 

Presented by:
Luke O’Neill PhD FRS
Professor of Biochemistry, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin




ATCC logo website Cell Health and Viability

Assessing cell viability and cell health is crucial to all aspects of cell culture. In addition to the proper maintenance of cell stocks, cell health practices increase the level of confidence in experimental results.

Presented by:
Steven Budd, M.S., MBA Product Line Business Specialist, ATCC Cell Systems


ACD Biotechne CMYKOptimize Your RNAscope® Assay Data

In this webinar we present best methods to analyze and present RNAscope® assay data.

Presented by:
Annelies Laeremans - Ph.D. Scientist, Advanced Cell Diagnostics, Inc.


AgilentType 1 Interferons Induce Changes in Core Metabolism that are Critical for Immune Function

Presented by:
Duojiao Wu, M.D., Ph.D. - Associate Professor in Zhongshan Hospital, Fudan University, Principle Investigator and Director of Systems Immunology. Group/Platform in Shanghai Institute of Clinical Bioinformatics


AgilentSystems-based approach to characterizing human pluripotent stem cell metabolism

Presented by:
Hui (Sunny) Zhang - Research Professor. Zhongshan Medical School, Sun Yat-sen University in Guangzhou, China




This webinar will explore the intricate links between immunology and metabolism.

Presented by:
Lydia Lynch - Associate Professor. Trinity College Dublin Instructor, Harvard Medical School
Christoph Hess - Professor of Medicine. University Hospital Basel
Nicholas Restifo - Senior Investigator. National Cancer Institute
Moderator: Anne Granger - Scientific Editor, Cell Metabolism


AgilentWorking Towards Defining a Metabolic Roadmap for Stem Cell Lineage Progression
Learn why metabolism is important – think beyond cellular energetics and how metabolism changes in different stem cell populations (eSCs, iPSCs and adult SCs).

Presented by:
Dr. James Ryall
Department of Physiology
The University of Melbourne


ACD Biotechne CMYKThe Next Generation RNA In Situ Hybridization Technologies|
In Vitro Technologies are proud to invite Dr Yuling Luo, President of Advanced Cell Diagnostics to present a seminar series on Next Generation RNA In Situ Hybridization Technologies For Research and Diagnostics.

Presented By:
Dr Yuling Luo
President of Advanced Cell Diagnostics




ATCC logo websiteATCC Microbiology Webinar – Best Practices for Stock Maintenance
Join us on Thursday, May 18 to hear Ms. Carol Horton discuss the best practices for stock maintenance with regard to passage, storage, recovery, and microbial authentication, and how ATCC manages these through the seed stock concept, adhering to the specific needs of each culture, and polyphasic strain authentication.

Presented by:
Carol Horton, M.S.
Marketing Manager, ATCC






ACD BiotechneRNAscope® Assay Data Analysis 
Getting good conclusive results from your experiments begins with accurate analysis of your data. In this webinar, we will focus on the RNAscope® Assay and the following topics:

  • Review RNA ISH images with poor, medium and high quality targets
  • RNA ISH scoring tips RNA ISH data in comparison with IHC
  • Discuss a specific data set for HPV detection in FFPE tissue samples

Presented by:
Dr. Nancy Ciau
Board Certified Pathologist,
Advanced Cell Diagnostics, Inc.


rnd logoNext Generation Targets for Immuno-oncology
Please join us for our webinar on Next Generation Targets for Immuno-Oncology. This webinar will discuss novel immunoregulatory pathways that we have uncovered as potential targets for oncology research and cancer immunotherapy.

Anthony Person, PhD
Manager in Bioassay Development


atcc webinar

Cell Line Contamination – Mycoplasma Prevention and Detection

Mycoplasma infection can deprive host cells of nutrients and induce global changes in host gene expression, which in turn can affect data reproducibility and lead to the misinterpretation of experimental results. Best practices in cell culture coupled with routine testing is critical for the prevention and early detection of mycoplasma contamination.

Key points:

  • Mycoplasma contamination significantly affects cell line physiology, resulting in erroneous data and misinterpretation of results.
  • Laboratory best practices and routine testing are essential for minimizing mycoplasma contamination.
  • ATCC provides all three of the common methods of mycoplasma detection, including direct culture, Hoechst DNA staining, and PCR-based testing.


Thursday, September 20, 2018
2:00 am Tuesday, in Sydney NSW

Presented by:

Reed Shabman, Ph.D.,
Lead Scientist, ATCC Standards Resources Center

Balsam Shawky, M.S.,
Senior Biologist, ATCC Standards Resource Center


/brands/agilent-technologies-seahorse-bioscience/Agilent Seahorse Webinar - Cell Analysis
Exploring the metabolism of CAR-T cells
In this webinar we will discuss:
- How CAR-T cells containing 4-1BB signaling domains have enforced in vitro persistence
- 4-1BB-enforced metabolic reprogramming enhances oxidative metabolism
- Mitochondrial biogenesis is selectively induced in 4-1BB CAR-T cells.

Presented by:
Roddy O'Connor, PhD
University of Pennsylvania
Center for Cellular Immunotherapies





/brands/agilent-technologies-seahorse-bioscience/Combining Seahorse XF Analysis with stable isotope tracing to reveal novel metabolic drug targets

This webinar will discuss how merging quantitative, rate-based measurements of oxygen consumption with detailed pathway analysis using mass spectrometry have revealed the mitochondrial pyruvate carrier (MPC) as a central regulator of metabolic flexibility.

Presented by:
Ajit Divakaruni - Assistant Professor, Molecular and Medical Pharmacology, University of California, Los Angeles (UCLA)


ACD BiotechneGet the most out of your RNAscope® Multiplex Fluorescent assays

RNAscope® Multiplex Fluorescent assays are ideal for single-molecule detection of multiple RNA targets simultaneously within the same tissue. They are very powerful in identifying co-expression or co-localization of RNA within specific sub-populations of cells.

Presented by:
Ming Xiao He
, Ph.D, Scientist, Marie Lauigan Technical Support Scientist.


AgilentiPSC-derived neural cells for drug discovery of mitochondrial disorders  

Mutations in mitochondrial DNA (mtDNA) cause diseases typically affecting the nervous system and for which no effective treatment exists.

Presented by:
Alessandro Prigione, M.D, Ph.D.
Independent Team Leader
Max Delbrueck Center for Molecular Medicine (MDC) in Berlin


ATCC logo websiteHuman Renal Proximal Tubule Epithelial Cells (RPTEC/TERT1) Modified to Express Drug Transporters - a New Model for Toxicity Studies

In vivo studies have shown that kidney membrane transporters play a key part in drug disposition and renal clearance. Primary renal proximal tubule epithelial cells (RPTEC) are the most physiologically relevant cell models, but lose OAT1 and OCT2 transporter expression in culture.

Presented by:
Chaozhong Zou, Ph.D. 

Senior Scientist,
ATCC Cell Systems


ACD BiotechneTips & Tricks to Get Publication Quality RNA ISH Data for Neuroscience Applications

RNAscope® Technology is a novel in situ hybridization (ISH) assay for detection of target RNA within intact cells. It represents a major advancement in RNA ISH approaches. 
In this webinar we will discuss the benefits of both RNAscope® and BaseScope™ assays and share tips and tricks on how to perform these assays successfully to obtain publication-quality RNA in situ results.

This webinar will benefit both new and experienced RNAscope® technology users.

Presented by:
Nidhi Vashistha, Ph.D

Technical Support Scientist
Advanced Cell Diagnostics, Inc


ATCC logoAdvanced Models of Parkinson's Disease

Optimized cell lines are essential for modeling neurodegenerative diseases, screening novel therapeutics, and testing the neurotoxicity of environmental compounds.  Neural progenitor cells (NPCs) derived from induced pluripotent stem cells are excellent in vitro models as they can be induced to differentiate down all three neural lineages.

Brian Shapiro, Ph.D. 
Technical Writer, ATCC


/brands/agilent-technologies-seahorse-bioscience/Metabolic switches that drive stem cell specification and differentiation to a mature neuron

As pluripotent stem cells become specified towards a neural stem/progenitor cell and then further differentiate into a mature neural cell type, they go through a number of molecular and metabolic changes that shift the balance between glycolysis and oxidative phosphorylation. Through the differentiation process stem cells turn off their dependence on glycolysis and move towards oxidative phosphorylation. However, whether the lineage specific gene expression drives the metabolic switch or vice versa remains unknown and is an aspect the we will further explore in this webinar.

Presented by:
Eva Szabo MSc, PhD
Canada Research Chair in Metabolism in Human Stem Cells and Cancer Development
Principal Investigator - Stem Cell and Cancer Research Institute (SCC-RI)
Assistant Professor - Biochemistry and Biomedical Sciences and Department of Medicine
Michael G. DeGroote School of Medicine
McMaster University


/brands/atccCreating Synthetic Protein-Protein Interaction Networks and Implications for Endogenous Network Discovery

Cells utilize networks that span both temporal and spatial organizations, encompassing many individual steps of regulation. While the regulatory regimes to build networks in synthetic biology has grown from solely transcription to also include protein or RNA modalities, circuits comprised solely of protein-protein interactions have yet to be produced.

Deepak Mishra, Sc.D.
Postdoctoral fellow, MIT


/brands/agilent-technologies-seahorse-bioscience/Normalizing Your Seahorse XF Data with Automated Cell Counting

In this webinar we will discuss:

  • Why normalize Seahorse XF data at all?
  • Considerations for choosing a normalization method.
  • How automated cell counting can improve your data quality.
  • How to use Seahorse software tools to streamline data analysis.

Presented By:
Brian Dranka, Ph.D.
Biology Manager, Seahorse XF Products 
Agilent Technologies, Inc.


/brands/agilent-technologies-seahorse-bioscience/Stem Cell Metabolism Webinar

Recent work has emphasized the importance of metabolic states and energy balance in maintaining stem cell function. Studies at the interface of stem cell biology and metabolism have investigated how metabolic flux is linked to changes in cell fate and dysfunction and have highlighted potential strategies to restore or manipulate stem cell metabolism for therapeutic gains in aging and disease.

In this Cell Press webinar, Alessandro Prigione (MDC), Heather Christofk (UCLA), and Michael Teitell (UCLA) will discuss their work studying metabolic regulation of pluripotency and reprogramming, and provide insights into how cellular metabolism controls self-renewal, differentiation, and survival of human pluripotent stem cells

Presented by:
Alessandro Prigione
Independent Team Leader
Heather Christofk
Associate Professor, Biological Chemistry, Molecular & Medical Pharmacology
Michael Teitell
Professor, Latta Endowed Chair and Chief of the Division of Pediatric and Neonatal Pathology
Jon Saxe
Scientific Editor, Cell Stem Cell


/brands/agilent-technologies-seahorse-bioscience/Quantifying Cellular ATP Production Rate Using Agilent Seahorse XF Technology

  • How the new Seahorse XF Real-Time ATP Production Rate Assay quantifies ATP production from Oxygen Consumption Rate (OCR) and Extracellular Acidification Rates (ECAR) measurements.
  • Why ATP Production Rate is more informative than end-point total ATP level assays to provide information about cellular activities and energy demand.
  • How to apply the assay to quantify cellular metabolic phenotypes, detect and quantify metabolic switching and uncover pathway or fuel liabilities.

David Ferrick, PhD
Senior Director Marketing
Cell Analysis Division, Agilent